Sio Capital Management »

Humacyte shares owned by Sio Capital Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.2M 2.0M 3.11
2022-12-31 $20k 50k 0.41

More positions owned by Sio Capital Management

Laboratory Corporation Of America Holdings Com New (LH)
Insmed Com Par $.01 Put Option (INSM)
Cigna Corp (CI)
Globus Medical Cl A (GMED)
Madrigal Pharmaceuticals (MDGL)
GSK Sponsored Adr (GSK)
Zimmer Holdings (ZBH)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Medtronic SHS (MDT)
Organon & Co Common Stock (OGN)
Tyra Biosciences (TYRA)
Embecta Corp Common Stock (EMBC)
Teleflex Incorporated (TFX)
Arcutis Biotherapeutics (ARQT)
Bridgebio Pharma (BBIO)

View all positions for Sio Capital Management

Top funds holding Humacyte

BlackRock
Vanguard Group
AIGH Capital Management
Sio Capital Management
Geode Capital Management
Monashee Investment Management
Prescott General Partners
Northern Trust
Charles Schwab Investment Management
LPL Financial
Citadel Advisors
Private Advisor
Capstone Investment Advisors
Millennium Management
Lion Point Capital

View all funds holding Humacyte